SCDM Executive Committee Perspective: The Future of Clinical Trials with AI and Decentralized, Hybrid and Data-driven approaches

The landscape of clinical trials is rapidly evolving, driven by advancements in Artificial Intelligence (AI) and the shift towards decentralized, hybrid models. This perspective explores two critical topics: 1. The role of AI in revolutionizing clinical trials while ensuring ethical standards.2. The utilization of real-world data (RWD) to enhance patient-centric research. Together, these themes highlight the potential for transforming clinical research into a more efficient, equitable, and effective endeavor.